BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 30407884)

  • 1. Novel germline missense DDX41 variant in a patient with an adult-onset myeloid neoplasm with excess blasts without dysplasia.
    Vairo FPE; Ferrer A; Cathcart-Rake E; King RL; Howard MT; Viswanatha DS; Klee EW; Mangaonkar AA; Patnaik MM
    Leuk Lymphoma; 2019 May; 60(5):1337-1339. PubMed ID: 30407884
    [No Abstract]   [Full Text] [Related]  

  • 2. DDX41 mutations in myeloid neoplasms are associated with male gender, TP53 mutations and high-risk disease.
    Quesada AE; Routbort MJ; DiNardo CD; Bueso-Ramos CE; Kanagal-Shamanna R; Khoury JD; Thakral B; Zuo Z; Yin CC; Loghavi S; Ok CY; Wang SA; Tang Z; Bannon SA; Benton CB; Garcia-Manero G; Kantarjian H; Luthra R; Medeiros LJ; Patel KP
    Am J Hematol; 2019 Jul; 94(7):757-766. PubMed ID: 30963592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case Report of a Myeloid Neoplasm with Pathogenic Germline Variant in DDX41 and Constitutional inv(7)(q11.2q22) Along With JAK2 Pathogenic Variant in a 9-Year-old Patient Who Presented With Features of Essential Thrombocythemia.
    Gray AL; Liu Y; Wappler-Guzzetta EA; Cherukuri D; Wang J; Jain A
    J Pediatr Hematol Oncol; 2023 Jul; 45(5):e609-e612. PubMed ID: 37278578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel DDX41 variants in Thai patients with myeloid neoplasms.
    Polprasert C; Takeda J; Niparuck P; Rattanathammethee T; Pirunsarn A; Suksusut A; Kobbuaklee S; Wudhikarn K; Lawasut P; Kongkiatkamon S; Chuncharunee S; Songserm K; Phowthongkum P; Bunworasate U; Nannya Y; Yoshida K; Makishima H; Ogawa S; Rojnuckarin P
    Int J Hematol; 2020 Feb; 111(2):241-246. PubMed ID: 31713024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The genetic landscape of germline DDX41 variants predisposing to myeloid neoplasms.
    Li P; Brown S; Williams M; White T; Xie W; Cui W; Peker D; Lei L; Kunder CA; Wang HY; Murray SS; Vagher J; Kovacsovics T; Patel JL
    Blood; 2022 Aug; 140(7):716-755. PubMed ID: 35671390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Makishima H, Saiki R, Nannya Y, et al. Germ line DDX41 mutations define a unique subtype of myeloid neoplasms. Blood. 2023;141(5):534-549.
    Blood; 2024 May; 143(18):1879. PubMed ID: 38696198
    [No Abstract]   [Full Text] [Related]  

  • 7. [Myeloid neoplasms with germline predisposition].
    Yoshida K
    Rinsho Ketsueki; 2023; 64(9):949-954. PubMed ID: 37793870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DDX41: the poster child for familial MDS/AML grows up.
    Truong P; Pimanda JE
    Blood; 2023 Feb; 141(5):447-449. PubMed ID: 36729548
    [No Abstract]   [Full Text] [Related]  

  • 9. DDX41-associated susceptibility to myeloid neoplasms.
    Makishima H; Bowman TV; Godley LA
    Blood; 2023 Mar; 141(13):1544-1552. PubMed ID: 36455200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Putative new childhood leukemia cancer predisposition syndrome caused by germline bi-allelic missense mutations in DDX41.
    Diness BR; Risom L; Frandsen TL; Hansen B; Andersen MK; Schmiegelow K; Wadt KAW
    Genes Chromosomes Cancer; 2018 Dec; 57(12):670-674. PubMed ID: 30144193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloid neoplasms with germline DDX41 mutation.
    Cheah JJC; Hahn CN; Hiwase DK; Scott HS; Brown AL
    Int J Hematol; 2017 Aug; 106(2):163-174. PubMed ID: 28547672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and molecular correlates of somatic and germline
    Badar T; Nanaa A; Foran JM; Viswanatha D; Al-Kali A; Lasho T; Finke C; Alkhateeb HB; He R; Gangat N; Shah M; Tefferi A; Mangaonkar AA; Litzow MR; Ongie LJ; Chlon T; Ferrer A; Patnaik MM
    Haematologica; 2023 Nov; 108(11):3033-3043. PubMed ID: 37199125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two novel germline DDX41 mutations in a family with inherited myelodysplasia/acute myeloid leukemia.
    Li R; Sobreira N; Witmer PD; Pratz KW; Braunstein EM
    Haematologica; 2016 Jun; 101(6):e228-31. PubMed ID: 26944477
    [No Abstract]   [Full Text] [Related]  

  • 14. Germ line DDX41 mutations define a unique subtype of myeloid neoplasms.
    Makishima H; Saiki R; Nannya Y; Korotev S; Gurnari C; Takeda J; Momozawa Y; Best S; Krishnamurthy P; Yoshizato T; Atsuta Y; Shiozawa Y; Iijima-Yamashita Y; Yoshida K; Shiraishi Y; Nagata Y; Kakiuchi N; Onizuka M; Chiba K; Tanaka H; Kon A; Ochi Y; Nakagawa MM; Okuda R; Mori T; Yoda A; Itonaga H; Miyazaki Y; Sanada M; Ishikawa T; Chiba S; Tsurumi H; Kasahara S; Müller-Tidow C; Takaori-Kondo A; Ohyashiki K; Kiguchi T; Matsuda F; Jansen JH; Polprasert C; Blombery P; Kamatani Y; Miyano S; Malcovati L; Haferlach T; Kubo M; Cazzola M; Kulasekararaj AG; Godley LA; Maciejewski JP; Ogawa S
    Blood; 2023 Feb; 141(5):534-549. PubMed ID: 36322930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between GATA2 and DDX41-mutated myeloid neoplasms.
    Nanaa A; He R; Viswanatha D; Nguyen P; Jevremovic D; Foran JM; Yi CA; Greipp PT; Gangat N; Patnaik M; Tefferi A; Litzow MR; Mangaonkar AA; Shah MV; Badar T; Alkhateeb HB; Al-Kali A
    Leuk Res; 2022 Oct; 121():106931. PubMed ID: 36037623
    [No Abstract]   [Full Text] [Related]  

  • 16. [Lenalidomide for myelodysplastic syndrome with excess blasts with germline DDX41 mutation: a case report and literatures review].
    Chen J; Qu SQ; Qin TJ; Xiao ZJ; Xu ZF
    Zhonghua Xue Ye Xue Za Zhi; 2020 Oct; 41(10):857-860. PubMed ID: 33190445
    [No Abstract]   [Full Text] [Related]  

  • 17. Inherited and Somatic Defects in DDX41 in Myeloid Neoplasms.
    Polprasert C; Schulze I; Sekeres MA; Makishima H; Przychodzen B; Hosono N; Singh J; Padgett RA; Gu X; Phillips JG; Clemente M; Parker Y; Lindner D; Dienes B; Jankowsky E; Saunthararajah Y; Du Y; Oakley K; Nguyen N; Mukherjee S; Pabst C; Godley LA; Churpek JE; Pollyea DA; Krug U; Berdel WE; Klein HU; Dugas M; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Yoshida K; Ogawa S; Müller-Tidow C; Maciejewski JP
    Cancer Cell; 2015 May; 27(5):658-70. PubMed ID: 25920683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discriminating activities of DEAD-Box Helicase 41 from myeloid malignancy-associated germline variants by genetic rescue.
    Kim JA; Shen S; Matson DR; Lovrien LN; Smith-Simmer KJ; Keles S; Churpek JE; Bresnick EH
    Leukemia; 2023 Jan; 37(1):235-239. PubMed ID: 36347925
    [No Abstract]   [Full Text] [Related]  

  • 19. DDX41-related myeloid neoplasia.
    Maciejewski JP; Padgett RA; Brown AL; Müller-Tidow C
    Semin Hematol; 2017 Apr; 54(2):94-97. PubMed ID: 28637623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lifting the veil on germline DDX41 mutations.
    Sanders MA
    Blood; 2019 Oct; 134(17):1368-1370. PubMed ID: 31698430
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.